|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
|
GB9913458D0
(en)
*
|
1999-06-09 |
1999-08-11 |
Medeva Europ Ltd |
The therapeutic use of d-threo-methylphenidate
|
|
GB9918735D0
(en)
*
|
1999-08-09 |
1999-10-13 |
Straken Limited |
Transdermal patches
|
|
CO5261532A1
(es)
*
|
1999-11-15 |
2003-03-31 |
Novartis Ag |
Compuestos heterociclicos sililados, procedimiento para la preparacion de estos y composicion farmaceutica que los contiene
|
|
ES2210025T3
(es)
*
|
1999-12-17 |
2004-07-01 |
Celltech Pharma Europe Limited |
Agente farmaceutico para el tratamiento de estados convulsivos.
|
|
US6455066B1
(en)
|
2000-03-10 |
2002-09-24 |
Epicept Corporation |
Intradermal-penetration agents for topical local anesthetic administration
|
|
US6905016B2
(en)
*
|
2000-03-14 |
2005-06-14 |
Noven Pharmaceuticals, Inc. |
Packaging system for transdermal drug delivery systems
|
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
|
DE10060550C1
(de)
*
|
2000-12-06 |
2002-04-18 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
|
|
US7988991B2
(en)
*
|
2001-03-07 |
2011-08-02 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive patch
|
|
FR2822049B1
(fr)
*
|
2001-03-13 |
2003-08-01 |
Dbv Medica 1 |
Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
|
|
ES2270746T3
(es)
*
|
2001-03-16 |
2007-12-01 |
Alza Corporation |
Parche transdermico para administrar fentanilo.
|
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
|
DE10141652B4
(de)
*
|
2001-08-24 |
2011-04-07 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
|
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
|
US20030049272A1
(en)
*
|
2001-08-30 |
2003-03-13 |
Yatindra Joshi |
Pharmaceutical composition which produces irritation
|
|
JP4354678B2
(ja)
*
|
2002-08-28 |
2009-10-28 |
久光製薬株式会社 |
貼付剤
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
EP2959893A1
(en)
|
2002-12-13 |
2015-12-30 |
DURECT Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
|
NZ546992A
(en)
*
|
2003-10-28 |
2009-07-31 |
Noven Pharma |
Transdermal drug delivery device
|
|
AU2006206410B2
(en)
*
|
2005-01-20 |
2012-08-30 |
Ampio Pharmaceuticals, Inc. |
Methylphenidate derivatives and uses of them
|
|
ES2372004T3
(es)
*
|
2005-01-20 |
2012-01-12 |
Institute For Molecular Medicine, Inc. |
Usos de derivados de metilfenidato.
|
|
WO2007077029A1
(de)
*
|
2005-12-23 |
2007-07-12 |
Epinamics Gmbh |
Verwendung filmbildender haarpflegepolymere aus der gruppe der polyurethane und diese polymere enthaltende pharmazeutische zubereitungen und pflaster
|
|
US9393218B2
(en)
*
|
2005-12-23 |
2016-07-19 |
Epinamics Gmbh |
Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
|
|
EP1998756A2
(en)
*
|
2006-02-27 |
2008-12-10 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for delivery of amino-functional drugs
|
|
US8568695B2
(en)
*
|
2006-05-01 |
2013-10-29 |
Colgate-Palmolive Company |
Oral care composition with silicone composite
|
|
US20100104621A1
(en)
*
|
2007-02-21 |
2010-04-29 |
Connected Health Systems, Llc |
Treating adhd and other diseases involving inflammation
|
|
JP5687901B2
(ja)
*
|
2007-10-15 |
2015-03-25 |
アルザ・コーポレーシヨン |
日に１回の取り替えによるフェンタニルの経皮投与
|
|
FR2924350B1
(fr)
*
|
2007-12-03 |
2010-08-13 |
Dbv Tech |
Procede et compositions pour la vaccination par voie cutanee
|
|
FR2924349B1
(fr)
|
2007-12-03 |
2010-01-01 |
Dbv Tech |
Methode de desensibilitation aux allergenes
|
|
WO2009088414A2
(en)
|
2007-12-06 |
2009-07-16 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
US8795713B2
(en)
*
|
2007-12-31 |
2014-08-05 |
Acclarent, Inc. |
Mucosal tissue dressing and method of use
|
|
FR2926466B1
(fr)
*
|
2008-01-23 |
2010-11-12 |
Dbv Tech |
Procede de fabrication de patchs par electrospray
|
|
EP2300011A4
(en)
*
|
2008-05-27 |
2012-06-20 |
Dmi Life Sciences Inc |
THERAPEUTIC PROCESSES AND COMPOUNDS
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
JP5155128B2
(ja)
*
|
2008-12-11 |
2013-02-27 |
日東電工株式会社 |
メチルフェニデート貼付製剤
|
|
CA2976789C
(en)
*
|
2009-06-05 |
2019-12-31 |
Megtec Systems, Inc. |
Method of drying a web of printed material
|
|
EP2364695A1
(en)
|
2010-02-10 |
2011-09-14 |
Nitto Denko Corporation |
Methylphenidate patch preparation
|
|
US20110200663A1
(en)
*
|
2010-02-12 |
2011-08-18 |
Nitto Denko Corporation |
Methylphenidate patch preparation
|
|
US8927010B2
(en)
|
2011-03-23 |
2015-01-06 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
DK3272342T3
(da)
|
2011-03-23 |
2021-06-07 |
Ironshore Pharmaceuticals & Dev Inc |
Fremgangsmåder og sammensætninger til behandling af opmærksomhedsforstyrrelse
|
|
US11241391B2
(en)
|
2011-03-23 |
2022-02-08 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US9119809B2
(en)
|
2011-03-23 |
2015-09-01 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US10905652B2
(en)
|
2011-03-23 |
2021-02-02 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US9498447B2
(en)
|
2011-03-23 |
2016-11-22 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US9283214B2
(en)
|
2011-03-23 |
2016-03-15 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
|
US9603809B2
(en)
|
2011-03-23 |
2017-03-28 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
|
US8916588B2
(en)
|
2011-03-23 |
2014-12-23 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods for treatment of attention deficit hyperactivity disorder
|
|
US10292937B2
(en)
|
2011-03-23 |
2019-05-21 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
|
BR112014002084B1
(pt)
*
|
2011-07-28 |
2022-03-29 |
Kempharm, Inc |
Composição de pró-fármaco e uso de conjugado de metilfenidato
|
|
AR092999A1
(es)
|
2012-10-15 |
2015-05-13 |
Noven Pharma |
Composiciones y metodos para la administracion transdermica de metilfenidato
|
|
US9265458B2
(en)
|
2012-12-04 |
2016-02-23 |
Sync-Think, Inc. |
Application of smooth pursuit cognitive testing paradigms to clinical drug development
|
|
JP2016505006A
(ja)
|
2012-12-28 |
2016-02-18 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
レボノルゲストレル及びエチニルエストラジオール用の経皮薬物送達システム
|
|
US9295726B2
(en)
|
2012-12-28 |
2016-03-29 |
Noven Pharamceuticals, Inc. |
Multi-polymer compositions for transdermal drug delivery
|
|
US9380976B2
(en)
|
2013-03-11 |
2016-07-05 |
Sync-Think, Inc. |
Optical neuroinformatics
|
|
US11337936B2
(en)
|
2013-03-14 |
2022-05-24 |
Noven Pharmaceuticals, Inc. |
Amphetamine transdermal compositions with acrylic block copolymer
|
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
AR095260A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
|
|
AR095259A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
|
|
US9782383B2
(en)
|
2013-12-25 |
2017-10-10 |
Fujimoto Co., Ltd. |
Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
|
|
US9980921B2
(en)
*
|
2016-06-30 |
2018-05-29 |
Taho Pharmaceuticals Ltd. |
Transdermal delivery system containing methylphenidate or its salts and methods thereof
|
|
KR102413459B1
(ko)
|
2016-07-06 |
2022-06-24 |
듀렉트 코퍼레이션 |
약물 조성물, 장벽 층 및 약물 층을 갖는 경구 투여 형태
|
|
CN106511264A
(zh)
*
|
2016-11-15 |
2017-03-22 |
北京万全德众医药生物技术有限公司 |
一种盐酸哌甲酯口服溶液剂及其制备方法
|
|
WO2018107132A1
(en)
|
2016-12-11 |
2018-06-14 |
Kempharm, Inc. |
Compositions comprising methylphenidate-prodrugs, processes of making and using the same
|
|
EP3598982A1
(en)
|
2018-07-23 |
2020-01-29 |
Centre National De La Recherche Scientifique |
Bioconjugates of neuropeptides derivatives
|
|
JP7600661B2
(ja)
*
|
2020-12-11 |
2024-12-17 |
ａｒｔｉｅｎｃｅ株式会社 |
貼付剤
|